Equinor ASA: Notifiable trading
A primary insider and close associate in Equinor ASA (OSE: EQNR, NYSE: EQNR) have sold shares in Equinor ASA:
Hilde Møllerstad, board member in Equinor ASA, has on 30 October 2023 sold 2094 shares at a price of NOK 379.80 per share and 871 shares at a price of NOK 377.64 per share.
Jon Olav Li, close associate to board member Hilde Møllerstad, has on 30 October 2023 sold 1630 shares at a price of NOK 381.25 per share.
Details of the sales of shares are set forth in the attached notification.
This is information that Equinor ASA is obliged to make public pursuant to Article 19 of the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Alternus Energy Reports Third Quarter 2023 Financial Results28.11.2023 14:30:00 CET | Press release
DUBLIN, Ireland, Nov. 28, 2023 (GLOBE NEWSWIRE) -- International Renewable Independent Power Producer (IPP) Alternus Energy Group Plc (OSE: ALT) (the “Company” or “Alternus”) today announced unaudited U.S. GAAP financial results for the third quarter of 2023 under the US GAAP format. Q3 2023 Highlights Power production decreased by 5.4% YoY to 157 MWh due primarily to weather variances in Poland and the Netherlands.Revenue decreased by $1.9 million (15.3%) to $10.5 million compared to the same reporting period last year primarily because of lower electricity pricing in Poland and from lower irradiation levels due to seasonal weather conditions in Poland and the Netherlands.Gross profit increased by $0.5 million (6.4%) to $8.3 million resulting in gross margin of 79.0% as reduced revenues were offset by tightly controlled project operating costs.Selling and general expenses increased by $1 million (41%) YoY as the company grew personnel and infrastructure to drive development activities
Cellebrite Showcases Innovations in Digital Intelligence at Milipol 202328.11.2023 14:30:00 CET | Press release
Cellebrite demonstrates how agencies can increase productivity of digital investigations by making them smarter, more efficient and defensible TYSONS CORNER, Va. and PETAH TIKVA, Israel and PARIS, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd. (Nasdaq: CLBT), a global leader in Digital Intelligence (DI) solutions for the public and private sectors, continued its commitment to accelerating justice around the globe with a leading presence at Milipol, the preeminent global law enforcement and homeland security event held November 14-17, 2023 in Paris. In addition to serving as one of the show’s sponsors, Cellebrite’s senior leadership, sales and service teams engaged with law enforcement professionals from more than 100 countries to discuss industry best practices and showcase recent innovations and emerging digital solutions. Highlights of Cellebrite’s show presence include: EMEA Senior Leadership convening with dozens of law enforcement professionals to discuss best practices and
Evaxion to Unveil Potentially Groundbreaking AI-Immunology™ Precision Cancer Vaccine Concept28.11.2023 14:27:00 CET | Press release
Proof of Concept – Evaxion’s AI-Immunology™ platform demonstrates success in designing precision cancer vaccines in hematological cancers by targeting a novel class of antigensBroad Applicability – The vaccine concept holds tremendous potential, offering broad applicability and promising benefits for patients with hematological malignancies COPENHAGEN, Denmark, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, proudly announces the presentation of its novel precision vaccine concept at the 65th American Society of Hematology (ASH) Annual Meeting, taking place in San Diego, California, from December 9-12, 2023. Selected for an Oral Presentation – Evaxion has been chosen for an oral presentation from a competitive pool of >5000 submitted abstracts. The presentation will unveil a breakthrough achievement using the Company’s proprietary AI target dis
Finanskalender 2024 for Djurslands Bank A/S28.11.2023 14:24:56 CET | pressemeddelelse
Fondsbørsmeddelelse 18/2023 I henhold til gældende oplysningsforpligtelser følger hermed finanskalender med forventede datoer for offentliggørelser m.m. for regnskabsåret 2024. 20. februar 2024Årsrapport for 202319. marts 2024Ordinær generalforsamling *)15. maj 2024Kvartalsrapport for 1. kvartal 202416. august 2024Halvårsrapport for 1. halvår 2024 8. november 2024 Kvartalsrapport for 1. – 3. kvartal 2024 *) Jævnfør vedtægternes §7 stk. 2 skal forslag fra aktionærerne være indleveret skriftligt til bestyrelsen senest 6 uger før generalforsamlingens afholdelse, svarende til den 5. februar 2024, for at komme til behandling på generalforsamlingen. Med venlig hilsen Djurslands Bank Sigurd Simmelsgaard Adm. direktør Vedhæftet fil 18-2023 Finanskalender 2024 Djurslands Bank
TRESU Investment Holding A/S – Announcement of Q3 2023 Interim Report28.11.2023 14:07:53 CET | Press release
TRESU INVESTMENT HOLDING A/S ANNOUNCEMENT NO. 08.2023 28.11.2023 TRESU Investment Holding A/S – Announcement of Q3 2023 Interim Report Tresu Investment Holding A/S today publishes the Q3 2023 Interim Report and presentation of the financial results. We are pleased to invite you to the financial results call, which is being held Friday, 1 December 2023, at 12:30am CET. The Interim Report will be presented by Stephan Plenz, CEO and Torben Børsting, CFO. After the presentations there will be an opportunity for Q+A. A recording of the results call will be made available for four hours on the TRESU IR website. To register for the investor call, please send an e-mail to Financial manager at TRESU A/S Finn Holm no later than 30 November 2023 9am CET - fho@tresu.com Stephan plenz CEO, TRESU For further details, please contact: CEO, Stephan Plenz, phone: +45 2194 5480 CFO, Torben Børsting, phone: +45 5130 2780 Attachments Quarterly reporting - 2023 Q3Tresu Investment Holding interim report 2023